Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Xenon Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference


Xenon Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference

BURNABY, British Columbia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's President and Chief Executive Officer, will present a corporate update at the Stifel 2017 Healthcare Conference in New York, NY on Tuesday, November 14, 2017 at 2:00 pm ET.

A live audio webcast of the presentation will be available on the investors section of Xenon's website at www.xenon-pharma.com and will be available for replay following the event.

About Xenon Pharmaceuticals Inc.

Xenon is a clinical stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Building upon our extensive knowledge of human genetics and diseases caused by mutations in ion channels, known as channelopathies, we are advancing ? both independently and with our pharmaceutical collaborators ? a novel product pipeline of ion channel modulators to address therapeutic areas of high unmet medical need, such as pain and epilepsy. For more information, please visit www.xenon-pharma.com.

Investor/Media Contact:
Jodi Regts
VP, Corporate Affairs & Investor Relations
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected]

 


These press releases may also interest you

at 13:30
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS' first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major step forward in the...

at 13:25
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...

at 13:15
Dr. Christine Bradaric-Baus Named President of the Canadian Memorial Chiropractic College
The Board of Governors of the Canadian Memorial Chiropractic College (CMCC) is delighted to announce the appointment of Dr. Christine Bradaric-Baus as its next President, effective July 1, 2024, following the retirement of President...

at 13:13
Hoag Family Cancer Institute Welcomes Oncology 'Power Couple'
Hoag is proud to announce the recruitment of cancer researchers and subspecialized oncologists Monica Mita, M.D., M.Sc., Mh.D.S., and Alain Mita, M.D., M.Sc., to the Hoag Family Cancer Institute....

at 13:02
Sorcero Announces New Scientific Sentimenttm to Revolutionize Pharma Engagement Strategies
Sorcero, the leading provider of advanced AI solutions purpose-built for life sciences, today announced the release of Scientific Sentiment, enabling Life Sciences teams, for the first time, to quantify product perception across KOLs and the market...

at 13:00
Uwill Honored by EdTech Digest Awards as Best Higher Education Solution
Uwill, the leading mental health and wellness solution for students, proudly announces its inclusion on the prestigious EdTech Digest Awards 'Cool Tool' list for 'Best Higher Education Solution'. This acknowledgement highlights Uwill's commitment to...

More news about Health...


News published on and distributed by: